129 related articles for article (PubMed ID: 12508357)
21. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus X protein induces the histone H3 lysine 9 trimethylation on the promoter of p16 gene in hepatocarcinogenesis.
Wang DY; Zou LP; Liu XJ; Zhu HG; Zhu R
Exp Mol Pathol; 2015 Dec; 99(3):399-408. PubMed ID: 26341139
[TBL] [Abstract][Full Text] [Related]
23. Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines.
Hao MW; Liang YR; Liu YF; Liu L; Wu MY; Yang HX
World J Gastroenterol; 2002 Apr; 8(2):203-7. PubMed ID: 11925592
[TBL] [Abstract][Full Text] [Related]
24. Expression of TNF-related apoptosis-inducing Ligand receptors and antitumor tumor effects of TNF-related apoptosis-inducing Ligand in human hepatocellular carcinoma.
Chen XP; He SQ; Wang HP; Zhao YZ; Zhang WG
World J Gastroenterol; 2003 Nov; 9(11):2433-40. PubMed ID: 14606071
[TBL] [Abstract][Full Text] [Related]
25. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
[TBL] [Abstract][Full Text] [Related]
26. Abrogation of the p16-Rb pathway in Korean hepatocellular carcinomas.
Lee TJ; Bae JJ; Lee JS; Lee SY; Kim HJ; Kim SK; Lee JY; Lee TY
Hepatogastroenterology; 2000; 47(36):1663-8. PubMed ID: 11149028
[TBL] [Abstract][Full Text] [Related]
27. Hypomethylation of
Pal D; Sur S; Roy R; Mandal S; Panda CK
J Biosci; 2021; 46():. PubMed ID: 34148876
[TBL] [Abstract][Full Text] [Related]
28. Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14.
Cho Y; Lee YB; Lee JH; Lee DH; Cho EJ; Yu SJ; Kim YJ; Kim JI; Im JH; Lee JH; Oh EJ; Yoon JH
PLoS One; 2016; 11(8):e0160822. PubMed ID: 27494117
[TBL] [Abstract][Full Text] [Related]
29. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
30. 20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription.
Li Q; Li B; Dong C; Wang Y; Li Q
Eur J Pharmacol; 2017 Nov; 815():173-180. PubMed ID: 28928088
[TBL] [Abstract][Full Text] [Related]
31. Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines.
Box AH; Demetrick DJ
Carcinogenesis; 2004 Dec; 25(12):2325-35. PubMed ID: 15347600
[TBL] [Abstract][Full Text] [Related]
32. Ultrasound-targeted HSVtk and Timp3 gene delivery for synergistically enhanced antitumor effects in hepatoma.
Yu BF; Wu J; Zhang Y; Sung HW; Xie J; Li RK
Cancer Gene Ther; 2013 May; 20(5):290-7. PubMed ID: 23598435
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
34. Effect of promoter methylation of the p16 gene on phosphorylation of retinoblastoma gene product and growth of hepatocellular carcinoma cells.
Maeta Y; Shiota G; Okano J; Murawaki Y
Tumour Biol; 2005; 26(6):300-5. PubMed ID: 16254459
[TBL] [Abstract][Full Text] [Related]
35. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G
Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052
[TBL] [Abstract][Full Text] [Related]
36. p16 Stimulates CDC42-dependent migration of hepatocellular carcinoma cells.
Chen YW; Chu HC; Ze-Shiang Lin ; Shiah WJ; Chou CP; Klimstra DS; Lewis BC
PLoS One; 2013; 8(7):e69389. PubMed ID: 23894465
[TBL] [Abstract][Full Text] [Related]
37. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation.
Wu C; Chen W; Fang M; Boye A; Tao X; Xu Y; Hou S; Yang Y
J Ethnopharmacol; 2019 Mar; 231():98-112. PubMed ID: 30412748
[TBL] [Abstract][Full Text] [Related]
38. Loss of p16(INK4) protein, alone and together with loss of retinoblastoma protein, correlate with hepatocellular carcinoma progression.
Hui AM; Shi YZ; Li X; Takayama T; Makuuchi M
Cancer Lett; 2000 Jun; 154(1):93-9. PubMed ID: 10799744
[TBL] [Abstract][Full Text] [Related]
39. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
[TBL] [Abstract][Full Text] [Related]
40. Effects of exogenous p16(ink4a) gene on biological behaviors of human lung cancer cells.
Zhang X; Jin Y; Tao X; Bai M
J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):37-40. PubMed ID: 17393105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
